Merck in Gender Bias Wrangle
Four class representatives have been added to a class-action gender-discrimination employment suit originally filed last May against Merck & Co. in New Jersey.
Four class representatives have been added to a class-action gender-discrimination employment suit originally filed last May against Merck & Co. in New Jersey.
According to Human Resources Executive Online (HREOnline), the suit alleges that all class representatives of the suit were highly regarded members of Merck’s salesforce until they became pregnant. Then the drug maker allegedly subjected the plaintiffs to hostility, discrimination, workplace reassignments that reduced their compensation and caused anxiety.
The additional claims raise the potential value of the case against Merck to $250 million. The law firm that added the four plaintiffs - Sanford Heisler - recently won a case against Novartis that cost the firm $253 million in damages.
Kate Mueting, of the plaintiffs’ legal team, told HREOnline that the suit is “further evidence of the pervasive nature of gender-based hostility throughout Merck’s U.S. salesforce.”
Merck responded with the statement: “We are confident that this case lacks merit, and the company will vigorously defend itself. Merck is fully committed to providing equal employment opportunities for all employees and has a strong anti-discrimination policy…”
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
